2022
DOI: 10.1101/2022.07.11.497949
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A comprehensive analysis of gut and skin microbiota in canine atopic dermatitis in Shiba Inu dogs

Abstract: Background: Like its human counterpart, canine atopic dermatitis (cAD) is a chronic relapsing condition; thus, most cAD-affected dogs will require lifelong treatment to maintain an acceptable quality of life. A potential intervention is modulation of the composition of gut microbiota, and in fact, probiotic treatment has been proposed and tried in human atopic dermatitis (AD) patients. Since dogs are currently receiving intensive medical care, this will be the same option for dogs, while evidence of gut dysbio… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 65 publications
0
2
0
Order By: Relevance
“…As a result of the disruption of the mucosal epithelial barrier in the leaky gut, allergens and toxins are thought to pass into the organism and predispose it to atopic dermatitis (Pascal et al, 2018;Thomsen et al, 2023). Dysbiotic microbiota crossing the damaged gut barrier may play a role in the development of allergies and autoimmune and chronic diseases (Akdis, 2021).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As a result of the disruption of the mucosal epithelial barrier in the leaky gut, allergens and toxins are thought to pass into the organism and predispose it to atopic dermatitis (Pascal et al, 2018;Thomsen et al, 2023). Dysbiotic microbiota crossing the damaged gut barrier may play a role in the development of allergies and autoimmune and chronic diseases (Akdis, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, it has been established in human medicine that chronic intestinal diseases (such as irritable colon syndrome, Crohn's disease and celiac disease) predispose to dysbiosis as a result of disruption of the intestinal microbiota or leaky gut by causing damage to the intestinal wall and that this condition may form the basis of the development of atopic dermatitis (Hua et al., 2016; Pascal et al., 2018; Rostaher et al., 2022; Salameh et al., 2019; Stewart et al., 2017). As a result of the disruption of the mucosal epithelial barrier in the leaky gut, allergens and toxins are thought to pass into the organism and predispose it to atopic dermatitis (Pascal et al., 2018; Thomsen et al., 2023). Dysbiotic microbiota crossing the damaged gut barrier may play a role in the development of allergies and autoimmune and chronic diseases (Akdis, 2021).…”
Section: Discussionmentioning
confidence: 99%